Should I buy ZoomInfo (GTM) stock or is it too late?
⭐ The most reliable of them, either direction: UBS — 62% of its targets hit on this sector (13 calls tested). It aims for $4.50 (+10 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).
✅ Reasons to believe
- The most reliable firm on GTM, Keybanc (100% hit rate, 2 scored calls), targets $10 (call made on November 4, 2025, maturing on November 4, 2026) (+145%) in its most recent call.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 13 ratings, 7 are neutral and 5 are sells.
- Limited upside: the median target is only -2% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on GTM
Median target $4 (-2%) · 13 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in ZoomInfo now?
We won't decide for you. The facts: 8% of analysts rate it a buy, median target $4 (-2%), and Keybanc (most reliable on GTM, 100%) targets $10. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in ZoomInfo?
The stated upside is small: the median target ($4) sits just -2% from the price ($4) (most reliable on GTM: Keybanc, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is ZoomInfo still worth investing in?
It depends on the gap between the price ($4) and its estimated value: analysts target $4 on median (-2%), with 8% buys (most reliable on GTM: Keybanc, 100%). Cross-check with their real reliability on GTM and the cautions above. Information, not advice.
What's the main risk in buying GTM?
The consensus is not unanimous: of 13 ratings, 7 are neutral and 5 are sells.
→ Go deeper: the full ZoomInfo profile (consensus, analyst reliability, price target, performance).